Philip William Addis

Title: The Innovative Contributions of Philip William Addis

Introduction

Philip William Addis is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunotherapy, particularly through his work on T cell receptors. With a total of four patents to his name, Addis is recognized for his innovative approaches to treating malignant diseases.

Latest Patents

Among his latest patents, Addis has developed T cell receptors (TCRs) that specifically bind to the HLA-A*02 restricted peptide SLLQHLIGL, which is derived from the germline cancer antigen PRAME. These TCRs may include non-natural mutations within the alpha and/or beta variable domains compared to a native PRAME TCR. The TCRs he has invented are particularly suitable for use as novel immunotherapeutic reagents aimed at treating malignant diseases.

Career Highlights

Addis is currently associated with Immunocore Limited, a company that focuses on developing innovative therapies for cancer treatment. His work has been instrumental in advancing the understanding and application of T cell receptors in immunotherapy.

Collaborations

Throughout his career, Addis has collaborated with several talented individuals, including Nicole Joy Bedke and Lucie Bouard. These collaborations have contributed to the successful development of his patented technologies.

Conclusion

Philip William Addis stands out as a prominent inventor in the field of immunotherapy, with a focus on T cell receptors that have the potential to revolutionize cancer treatment. His contributions continue to impact the medical community positively.